Table 1.
Characterization of the studied population
| Characteristics | RBG < 120 | RBG ≥ 120 | Total | P value |
|---|---|---|---|---|
| No. (%) | No. (%) | No. (%) | ||
| All patients | 95 (64 %) | 53 (36 %) | 148 (100 %) | |
| Age | 0.02 | |||
| Min | 29 | 28 | 28 | |
| Max | 89 | 85 | 89 | |
| Mean (SD) | 53.3 (13.3) | 57.4 (12.9) | 54.80 (13.3) | |
| Median | 50 | 56 | 53.0 | |
| <50 | 45 (47 %) | 15 (28 %) | 60 (41 %) | |
| ≥50 | 50 (53 %) | 38 (72 %) | 88 (59 %) | |
| Tumor grade | 0.14 | |||
| Grade I | 21 (22 %) | 5 (9 %) | 26 (18 %) | |
| Grade II | 34 (36 %) | 20 (38 %) | 54 (36 %) | |
| Grade III | 40 (42 %) | 28 (53 %) | 68 (46 %) | |
| Tumor stage | 0.19 | |||
| Stage I | 16 (17 %) | 4 (8 %) | 20 (14 %) | |
| Stage II | 75 (79 %) | 48 (91 %) | 123 (83 %) | |
| Stage III | 4 (4 %) | 1 (2 %) | 5 (3 %) | |
| Race | 0.05 | |||
| EA | 82 (86 %) | 38 (72 %) | 120 (81 %) | |
| AA | 13 (14 %) | 15 (28 %) | 28 (19 %) | |
| BMI | 0.1 | |||
| Min | 17 | 21 | 17 | |
| Max | 54 | 43 | 54 | |
| Mean (SD) | 28.5 (6.8) | 30.3 (6.3) | 29.1 (6.6) | |
| Median | 27 | 29 | 27 | |
| <30 | 61 (64 %) | 25 (47 %) | 49 (33 %) | |
| ≥30 | 28 (29 %) | 21 (40 %) | 86 (58 %) | |
| Unknown | 6 (6 %) | 7 (13 %) | 13 (9 %) | |
| Death | 20 (41 %) | 29 (59 %) | 49 (100 %) | |
| Recurrence | 16 (50 %) | 16 (50 %) | 32 (100 %) | |
| Median follow-up (years) | 6.27 | 5.14 | 5.97 |